Although chronic pain is one of the most important medical problems facing society, there has been very limited progress in the development of novel therapies for this condition. Here, we discuss high-impact research priorities to reduce the number of people transitioning from acute to chronic intractable pain.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A parabrachial hub for need-state control of enduring pain
Nature Open Access 08 October 2025
-
Site-specific drug release of monomethyl fumarate to treat oxidative stress disorders
Nature Biotechnology Open Access 04 November 2024
-
Degenerative and regenerative peripheral processes are associated with persistent painful chemotherapy-induced neuropathies in males and females
Scientific Reports Open Access 30 July 2024
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Ji, R. R., Chamessian, A. & Zhang, Y. Q. Science 354, 572–577 (2016).
Apkarian, A. V., Baliki, M. N. & Farmer, M. A. Curr. Opin. Neurol. 26, 360–367 (2013).
Denk, F., McMahon, S. B. & Tracey, I. Nat. Neurosci. 17, 192–200 (2014).
Skolnick, P. & Volkow, N. D. Neuron 92, 294–297 (2016).
Braz, J. M. et al. Neuron 74, 663–675 (2012).
Gewandter, J. S. et al. Pain 156, 1184–1197 (2015).
Acknowledgements
We thank the Interagency Pain Research Coordinating Committee of the US National Institutes of Health, who facilitated and provided financial support for meetings of the working group.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
RELATED LINKS
Federal Pain Research Strategy: https://iprcc.nih.gov/sites/default/files/iprcc/FPRS_Research_Recommendations_Final_508C.pdf
NIH policy: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-102.html
Supplementary information
Rights and permissions
About this article
Cite this article
Price, T.J., Basbaum, A.I., Bresnahan, J. et al. Transition to chronic pain: opportunities for novel therapeutics. Nat Rev Neurosci 19, 383–384 (2018). https://doi.org/10.1038/s41583-018-0012-5
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41583-018-0012-5
This article is cited by
-
Site-specific drug release of monomethyl fumarate to treat oxidative stress disorders
Nature Biotechnology (2025)
-
A parabrachial hub for need-state control of enduring pain
Nature (2025)
-
Hippocampal functional connectivity after whiplash injury is linked to the development of chronic pain
Nature Mental Health (2024)
-
Degenerative and regenerative peripheral processes are associated with persistent painful chemotherapy-induced neuropathies in males and females
Scientific Reports (2024)
-
NAAA-regulated lipid signaling in monocytes controls the induction of hyperalgesic priming in mice
Nature Communications (2024)
